“We welcome Rob’s experience and leadership to the Robert Talbott, Inc. community,” commented CEO Robert Corliss. “In his new role as chief financial officer, he will be responsible for leading the company on operational improvement, deployment and effective use of capital, and interacting with stakeholders of Robert Talbott, Inc. to achieve common goals. His results-oriented approach and ability to think creatively and strategically will play a pivotal role in extending the company’s product lines and growing profitability.”
Over his 25-year career, Bernosky has also been the CFO of Inclinix and Lyon Clinical Partners, two companies in the pharmaceutical industry.
Bernosky replaces Mark Donovan, who had joined the company in March.